BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 20547128)

  • 1. Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease.
    Cortes-Canteli M; Paul J; Norris EH; Bronstein R; Ahn HJ; Zamolodchikov D; Bhuvanendran S; Fenz KM; Strickland S
    Neuron; 2010 Jun; 66(5):695-709. PubMed ID: 20547128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction.
    Chung YC; Kruyer A; Yao Y; Feierman E; Richards A; Strickland S; Norris EH
    J Thromb Haemost; 2016 Jul; 14(7):1442-52. PubMed ID: 27090576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral amyloid angiopathy-linked β-amyloid mutations promote cerebral fibrin deposits via increased binding affinity for fibrinogen.
    Cajamarca SA; Norris EH; van der Weerd L; Strickland S; Ahn HJ
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14482-14492. PubMed ID: 32518112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice.
    Ahn HJ; Glickman JF; Poon KL; Zamolodchikov D; Jno-Charles OC; Norris EH; Strickland S
    J Exp Med; 2014 Jun; 211(6):1049-62. PubMed ID: 24821909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The APOE ɛ4/ɛ4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients.
    Hultman K; Strickland S; Norris EH
    J Cereb Blood Flow Metab; 2013 Aug; 33(8):1251-8. PubMed ID: 23652625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease peptide beta-amyloid interacts with fibrinogen and induces its oligomerization.
    Ahn HJ; Zamolodchikov D; Cortes-Canteli M; Norris EH; Glickman JF; Strickland S
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21812-7. PubMed ID: 21098282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen and altered hemostasis in Alzheimer's disease.
    Cortes-Canteli M; Zamolodchikov D; Ahn HJ; Strickland S; Norris EH
    J Alzheimers Dis; 2012; 32(3):599-608. PubMed ID: 22869464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin deposited in the Alzheimer's disease brain promotes neuronal degeneration.
    Cortes-Canteli M; Mattei L; Richards AT; Norris EH; Strickland S
    Neurobiol Aging; 2015 Feb; 36(2):608-17. PubMed ID: 25475538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated accumulation of fibrinogen peptide chains with Aβ deposition in Alzheimer's disease (AD) mice and human AD brains.
    Bian Z; Yamashita T; Shi X; Feng T; Yu H; Hu X; Hu X; Bian Y; Sun H; Tadokoro K; Takemoto M; Omote Y; Morihara R; Abe K
    Brain Res; 2021 Sep; 1767():147569. PubMed ID: 34197775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Amyloid Orchestrates Factor XII and Platelet Activation Leading to Endothelial Dysfunction and Abnormal Fibrinolysis in Alzheimer Disease.
    García-Mejía KA; Custodio-Chablé SJ; Vázquez-Franco JE; Reyes-Maldonado E; Lezama RA
    Alzheimer Dis Assoc Disord; 2021 Jan-Mar 01; 35(1):91-97. PubMed ID: 33629978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope Mapping Immunoassay Analysis of the Interaction between β-Amyloid and Fibrinogen.
    Van Giau V; An SSA
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and structural analysis of the interaction between β-amyloid and fibrinogen.
    Zamolodchikov D; Berk-Rauch HE; Oren DA; Stor DS; Singh PK; Kawasaki M; Aso K; Strickland S; Ahn HJ
    Blood; 2016 Aug; 128(8):1144-51. PubMed ID: 27389717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminopyrimidine Class Aggregation Inhibitor Effectively Blocks Aβ-Fibrinogen Interaction and Aβ-Induced Contact System Activation.
    Singh PK; Kawasaki M; Berk-Rauch HE; Nishida G; Yamasaki T; Foley MA; Norris EH; Strickland S; Aso K; Ahn HJ
    Biochemistry; 2018 Feb; 57(8):1399-1409. PubMed ID: 29394041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Alzheimer's disease peptide β-amyloid promotes thrombin generation through activation of coagulation factor XII.
    Zamolodchikov D; Renné T; Strickland S
    J Thromb Haemost; 2016 May; 14(5):995-1007. PubMed ID: 26613657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
    J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy.
    Singh PK; Berk-Rauch HE; Soplop N; Uryu K; Strickland S; Ahn HJ
    J Vis Exp; 2018 Nov; (141):. PubMed ID: 30582601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
    Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
    J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of β-amyloid peptide with fibrinogen and coagulation factor XII may contribute to Alzheimer's disease.
    Ahn HJ; Chen ZL; Zamolodchikov D; Norris EH; Strickland S
    Curr Opin Hematol; 2017 Sep; 24(5):427-431. PubMed ID: 28661939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum amyloid A binds to fibrin(ogen), promoting fibrin amyloid formation.
    Page MJ; Thomson GJA; Nunes JM; Engelbrecht AM; Nell TA; de Villiers WJS; de Beer MC; Engelbrecht L; Kell DB; Pretorius E
    Sci Rep; 2019 Feb; 9(1):3102. PubMed ID: 30816210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.